本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioRestorative Therapies, Inc.

0.2570
-0.0030-1.15%
盘后0.2547-0.0023-0.89%19:47 EDT
成交量:184.15万
成交额:46.75万
市值:654.79万
市盈率:-0.16
高:0.2603
开:0.2603
低:0.2466
收:0.2600
52周最高:2.05
52周最低:0.1900
股本:2,547.82万
流通股本:2,417.53万
量比:1.69
换手率:7.62%
股息:- -
股息率:- -
每股收益(TTM):-1.5837
每股收益(LYR):-1.5837
净资产收益率:-320.47%
总资产收益率:-119.56%
市净率:19.10
市盈率(LYR):-0.16

数据加载中...

2021/11/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

重要事件披露

8-K - Current report
2021/11/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/08

重要事件披露

8-K - Current report
2021/11/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/29

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/26

重要事件披露

8-K - Current report
2021/10/20

重要事件披露

8-K - Current report
2021/10/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/17

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/06

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans